Literature DB >> 23297724

Locoregional surgical and interventional therapies for advanced colorectal liver metastasis: expert consensus statement.

Robert C G Martin1, Riad Salem, Rene Adam, Elijah Dixon.   

Abstract

Entities:  

Mesh:

Year:  2013        PMID: 23297724      PMCID: PMC3719919          DOI: 10.1111/j.1477-2574.2012.00565.x

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN: 1365-182X            Impact factor:   3.647


× No keyword cloud information.
  19 in total

1.  Radiofrequency ablation combined with systemic treatment versus systemic treatment alone in patients with non-resectable colorectal liver metastases: a randomized EORTC Intergroup phase II study (EORTC 40004).

Authors:  T Ruers; C Punt; F Van Coevorden; J P E N Pierie; I Borel-Rinkes; J A Ledermann; G Poston; W Bechstein; M A Lentz; M Mauer; E Van Cutsem; M P Lutz; B Nordlinger
Journal:  Ann Oncol       Date:  2012-03-19       Impact factor: 32.976

2.  Morbidity of adjuvant hepatic arterial infusion pump chemotherapy in the management of colorectal cancer metastatic to the liver.

Authors:  Robert C G Martin; Michael J Edwards; Kelly M McMasters
Journal:  Am J Surg       Date:  2004-12       Impact factor: 2.565

3.  Hepatectomy after hepatic arterial therapy with either yttrium-90 or drug-eluting bead chemotherapy: is it safe?

Authors:  Russell E Brown; Matthew R Bower; Tiffany L Metzger; Charles R Scoggins; Kelly M McMasters; Michael J Hahl; Cliff Tatum; Robert C G Martin
Journal:  HPB (Oxford)       Date:  2010-12-22       Impact factor: 3.647

4.  Comparison of laparoscopic and open colorectal resections for patients undergoing simultaneous R0 resection for liver metastases.

Authors:  Jung Wook Huh; Yang Seok Koh; Hyeong Rok Kim; Chol Kyoon Cho; Young Jin Kim
Journal:  Surg Endosc       Date:  2010-06-12       Impact factor: 4.584

5.  Laparoscopic hepatic lobectomy: advantages of a minimally invasive approach.

Authors:  Robert C G Martin; Charles R Scoggins; Kelly M McMasters
Journal:  J Am Coll Surg       Date:  2010-05       Impact factor: 6.113

6.  Irinotecan drug-eluting beads in the treatment of chemo-naive unresectable colorectal liver metastasis with concomitant systemic fluorouracil and oxaliplatin: results of pharmacokinetics and phase I trial.

Authors:  Robert C G Martin; Charles R Scoggins; Dana Tomalty; Marshall Schreeder; Tiffany Metzger; Clifton Tatum; Vivek Sharma
Journal:  J Gastrointest Surg       Date:  2012-04-24       Impact factor: 3.452

7.  Toxicity of irinotecan-eluting beads in the treatment of hepatic malignancies: results of a multi-institutional registry.

Authors:  R C G Martin; J Howard; D Tomalty; K Robbins; R Padr; P M Bosnjakovic; Cliff Tatum
Journal:  Cardiovasc Intervent Radiol       Date:  2010-07-27       Impact factor: 2.740

Review 8.  Meta-analysis of hepatic arterial infusion for unresectable liver metastases from colorectal cancer: the end of an era?

Authors:  Simone Mocellin; Pierluigi Pilati; Mario Lise; Donato Nitti
Journal:  J Clin Oncol       Date:  2007-12-10       Impact factor: 44.544

9.  Laparoscopic-assisted combined colon and liver resection for primary colorectal cancer with synchronous liver metastases: initial experience.

Authors:  Seong Hoon Kim; Seok-Byung Lim; Yun Hyung Ha; Sung-Sik Han; Sang Jae Park; Hyo Seong Choi; Seung-Yong Jeong
Journal:  World J Surg       Date:  2008-12       Impact factor: 3.352

10.  Does Radiofrequency Ablation Add to Chemotherapy for Unresectable Liver Metastases?

Authors:  Klaas M Govaert; Charlotte S van Kessel; Martijn Lolkema; Theo J M Ruers; Inne H M Borel Rinkes
Journal:  Curr Colorectal Cancer Rep       Date:  2012-03-17
View more
  1 in total

1.  Efficacy and Toxicity of Hepatic Intra-Arterial Drug-Eluting (Irinotecan) Bead (DEBIRI) Therapy in Irinotecan-Refractory Unresectable Colorectal Liver Metastases.

Authors:  Neal Bhutiani; Olaguoke Akinwande; Robert C G Martin
Journal:  World J Surg       Date:  2016-05       Impact factor: 3.352

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.